Company intelligence / Profile preview

DeepMirror

Cambridge, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Platform validated by pharma and biotech clients (e.g., rapid identification of low off-target antimalarial compounds for Medicines for Malaria Venture, accelerated oncology candidate discovery), demonstrated ability to reduce time to identify leads from months to weeks or hours

Modalities: Small moleculePeptidesAntibody
Industry: Drug Discovery Services

Partnerships

Medicines for Malaria Venture (MMV)Innovate UKTES Pharma

Beyond the preview

Go deeper on DeepMirror.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DeepMirror.

Explore the full profile